Significance: Although the brain is protected by a tight physiological guardian named the blood–brain barrier (BBB), deposition of engineered nanomaterials (ENMs) in the brain and consequent neurotoxicity has been reported. To date, it is still unclear whether and how ENMs enter the brain by crossing the BBB. In this study, we found that metallic ENMs transform in the BBB as affected by their shape, size, and intrinsic solubility, which in turn modulates their transport form, efficiency, and pathways through the BBB and, consequently, their neurotoxicity. The library of quantitative data on the chemical transformations presented here will support in silico modeling and prediction of the neurotoxicity of NMs and facilitate the tailored design of safe NMs.
SWOT analysis of MOFs through the lens of safe and sustainable by design (SSbD) framework, highlighting their potential, challenges, and future directions (Prepared using Biorender Software).
Gold nanoparticles (AuNPs) are widely used in biomedicine due to their remarkable therapeutic applications. However, little is known about their cytotoxic effects on the ubiquitin proteasome system (UPS). Herein, the cytotoxicity of different sizes of AuNPs (5, 10, and 80 nm) on the UPS was investigated with a particular focus on deubiquitinating enzymes (DUBs) such as ubiquitin-specific proteases (USP) and ubiquitin carboxyl-terminal hydrolases (UCHL-1) in human alveolar epithelial adenocarcinoma (A549). It was found that all sizes of AuNPs reduced the percentage of viable A549 cells and increased lactate dehydrogenase (LDH) release, measured using the MTT and LDH assays, respectively. Furthermore, the 5 nm AuNPs were found to exhibit greater cytotoxicity than the 10 and 80 nm AuNPs. In addition, apoptosis and necrosis were activated through reactive oxygen species (ROS) generation due to AuNPs exposure. The internalisation of AuNPs in A549 cells increased with increasing particle size (80 > 10 > 5 nm). Interestingly, the expression of USP7, USP8, USP10, and UCHL-1 was significantly (p < 0.001) downregulated upon treatment with 5–30 µg/mL of all the AuNPs sizes compared to control cells. Moreover, the inhibition of these proteins triggered mitochondrial-related apoptosis through the upregulation of poly (ADP-ribose) polymerase (PARP), caspase-3, and caspase-9. Collectively, these results indicate that AuNPs suppress the proliferation of A549 cells and can potentially be used as novel inhibitors of the proteasome.
We report the development of CA-BNMG-1 composite beads-cellulose acetate macrobeads embedded with nanosized copper imidazolate MOFs (BNMG-1) -engineered via nonsolvent-induced phase separation for the selective recovery of rare earth elements (REEs) from complex aqueous environments. This encapsulation strategy ensures uniform MOF dispersion, enhanced mechanical integrity, and minimized Cu(II) leaching (<1%), fulfilling the Safe and Sustainable by Design (SSbD) criteria. The CA matrix not only mitigates copper toxicity but also enables facile bead handling, recyclability, and scalable deployment in fixed-bed systems. Adsorption studies across a 10-REE standard solution and two simulated waste streams demonstrated significantly improved REE selectivity over pristine BNMG-1. Separation factors (SFs) for Yb(III) over Mn(II), Ni(II), and Na(I) reached 194.5, 325.8, and 339, respectively; Eu(III) showed SFs of 155.5, 260.5, and 271.2. The beads retained over 95% of their uptake capacity across multiple adsorption and single desorption cycles using mild acidic eluents, confirming excellent reusability and structural stability. This work advances a robust, low-toxicity, and scalable REE recovery platform that integrates adsorptive performance with environmental safety. CA-BNMG-1 beads offer a compelling alternative to solvent extraction, with potential for integration into circular economy strategies targeting REE recovery from e-waste, mine tailings, and industrial effluents-addressing both resource security and sustainability challenges.